137 related articles for article (PubMed ID: 23817282)
1. Pretreatment predictors of short-term nonadherence to oral hormonal therapy for women with breast cancer.
Wickersham KE; Sereika SM; Bender CM
Nurs Res; 2013; 62(4):243-51. PubMed ID: 23817282
[TBL] [Abstract][Full Text] [Related]
2. Predicting nonadherence to adjuvant endocrine therapy in women with early stage breast cancer.
Corter AL; Broom R; Porter D; Harvey V; Findlay M
Psychooncology; 2018 Sep; 27(9):2096-2103. PubMed ID: 29776011
[TBL] [Abstract][Full Text] [Related]
3. Serum Detection of Nonadherence to Adjuvant Tamoxifen and Breast Cancer Recurrence Risk.
Pistilli B; Paci A; Ferreira AR; Di Meglio A; Poinsignon V; Bardet A; Menvielle G; Dumas A; Pinto S; Dauchy S; Fasse L; Cottu PH; Lerebours F; Coutant C; Lesur A; Tredan O; Soulie P; Vanlemmens L; Jouannaud C; Levy C; Everhard S; Arveux P; Martin AL; Dima A; Lin NU; Partridge AH; Delaloge S; Michiels S; André F; Vaz-Luis I
J Clin Oncol; 2020 Aug; 38(24):2762-2772. PubMed ID: 32568632
[TBL] [Abstract][Full Text] [Related]
4. Early discontinuation and nonadherence to adjuvant hormonal therapy in a cohort of 8,769 early-stage breast cancer patients.
Hershman DL; Kushi LH; Shao T; Buono D; Kershenbaum A; Tsai WY; Fehrenbacher L; Gomez SL; Miles S; Neugut AI
J Clin Oncol; 2010 Sep; 28(27):4120-8. PubMed ID: 20585090
[TBL] [Abstract][Full Text] [Related]
5. Clinical profiles predict early nonadherence to adjuvant endocrine treatment in a prospective breast cancer cohort.
Markkula A; Hietala M; Henningson M; Ingvar C; Rose C; Jernström H
Cancer Prev Res (Phila); 2012 May; 5(5):735-45. PubMed ID: 22401981
[TBL] [Abstract][Full Text] [Related]
6. Identification of subgroups of early breast cancer patients at high risk of nonadherence to adjuvant hormone therapy: results of an Italian survey.
Tinari N; Fanizza C; Romero M; Gambale E; Moscetti L; Vaccaro A; Seminara P; Longo F; Gori S; Vici P; Gamucci T; Mauri M; Laudadio L; Nuzzo A; Fabbri MA; Fattoruso SI; Mazzilli L; Grassadonia A; Cianchetti E; Natoli C
Clin Breast Cancer; 2015 Apr; 15(2):e131-7. PubMed ID: 25454738
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant therapy use among Appalachian breast cancer survivors.
Tan X; Marshall VD; Anderson RT; Donohoe J; Camacho F; Balkrishnan R
Medicine (Baltimore); 2015 Jul; 94(26):e1071. PubMed ID: 26131828
[TBL] [Abstract][Full Text] [Related]
8. The impact of symptom clusters on endocrine therapy adherence in patients with breast cancer.
Agnew S; Crawford M; MacPherson I; Shiramizu V; Fleming L
Breast; 2024 Jun; 75():103731. PubMed ID: 38599048
[TBL] [Abstract][Full Text] [Related]
9. Good adherence to adjuvant endocrine therapy in early breast cancer - a population-based study based on the Swedish Prescribed Drug Register.
Lundgren C; Lindman H; Rolander B; Ekholm M
Acta Oncol; 2018 Jul; 57(7):935-940. PubMed ID: 29493327
[TBL] [Abstract][Full Text] [Related]
10. Adherence to oral anticancer hormonal therapy in breast cancer patients and its relationship with treatment satisfaction: an important insight from a developing country.
Koni AA; Suwan BA; Nazzal MA; Sleem A; Daifallah A; Allah MH; Odeh RY; Zyoud SH
BMC Womens Health; 2023 Mar; 23(1):114. PubMed ID: 36941628
[TBL] [Abstract][Full Text] [Related]
11. Nonadherent behaviors among young women on adjuvant endocrine therapy for breast cancer.
Wassermann J; Gelber SI; Rosenberg SM; Ruddy KJ; Tamimi RM; Schapira L; Borges VF; Come SE; Meyer ME; Partridge AH
Cancer; 2019 Sep; 125(18):3266-3274. PubMed ID: 31120571
[TBL] [Abstract][Full Text] [Related]
12. Medication taking behaviors among breast cancer patients on adjuvant endocrine therapy.
Kimmick G; Edmond SN; Bosworth HB; Peppercorn J; Marcom PK; Blackwell K; Keefe FJ; Shelby RA
Breast; 2015 Oct; 24(5):630-6. PubMed ID: 26189978
[TBL] [Abstract][Full Text] [Related]
13. Factors associated with adherence and persistence to hormonal therapy in women with breast cancer.
Guedes JBR; Guerra MR; Alvim MM; Leite ICG
Rev Bras Epidemiol; 2017; 20(4):636-649. PubMed ID: 29267749
[TBL] [Abstract][Full Text] [Related]
14. Endocrine therapy for breast cancer: assessing an array of women's treatment experiences and perceptions, their perceived self-efficacy and nonadherence.
Wouters H; Stiggelbout AM; Bouvy ML; Maatman GA; Van Geffen EC; Vree R; Nortier JW; Van Dijk L
Clin Breast Cancer; 2014 Dec; 14(6):460-467.e2. PubMed ID: 24981234
[TBL] [Abstract][Full Text] [Related]
15. Adherence to Adjuvant Endocrine Therapy in Women With Breast Cancer: A Prospective Observational Study in Japanese Women.
Kuba S; Maeda S; Matsumoto M; Yamanouchi K; Yano H; Morita M; Sakimura C; Hatachi T; Tokai Y; Takatsuki M; Fujioka H; Hayashida N; Nagayasu T; Eguchi S
Clin Breast Cancer; 2018 Apr; 18(2):150-156. PubMed ID: 29290564
[TBL] [Abstract][Full Text] [Related]
16. Risks of nonadherence to hormone therapy in Asian women with breast cancer.
Hsieh KP; Chen LC; Cheung KL; Yang YH
Kaohsiung J Med Sci; 2015 Jun; 31(6):328-34. PubMed ID: 26043413
[TBL] [Abstract][Full Text] [Related]
17. Treatment Restarting After Discontinuation of Adjuvant Hormone Therapy in Breast Cancer Patients.
He W; Smedby KE; Fang F; Olsson H; Margolin S; Hall P; Czene K
J Natl Cancer Inst; 2017 Oct; 109(10):. PubMed ID: 28423398
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Adjuvant Radiation Therapy Alone Versus Radiation Therapy and Endocrine Therapy in Elderly Women With Early-Stage, Hormone Receptor-Positive Breast Cancer Treated With Breast-Conserving Surgery.
Murphy CT; Li T; Wang LS; Obeid EI; Bleicher RJ; Eastwick G; Johnson ME; Hayes SB; Weiss SE; Anderson PR
Clin Breast Cancer; 2015 Oct; 15(5):381-9. PubMed ID: 25861716
[TBL] [Abstract][Full Text] [Related]
19. Can demographic, clinical and treatment-related factors available at hormonal therapy initiation predict non-persistence in women with stage I-III breast cancer?
Cahir C; Barron TI; Sharp L; Bennett K
Cancer Causes Control; 2017 Mar; 28(3):215-225. PubMed ID: 28210883
[TBL] [Abstract][Full Text] [Related]
20. Patterns of endocrine therapy in a national cohort of early stage HER2-positive breast cancer patients.
Tervonen HE; Daniels B; Tang M; Preen DB; Pearson SA
Pharmacoepidemiol Drug Saf; 2019 Jun; 28(6):812-820. PubMed ID: 30861596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
